Biosurgery Market to Reach $28.37 billion with 9.2% CAGR Forecast to 2022

WiseGuy Market Research Report

Biosurgery Market to Grow at a 9.2% CAGR Forecast to 2022

PUNE, INDIA, October 12, 2016 /EINPresswire.com/ -- According to researcher, the Global Biosurgery market is estimated at $15.32 billion in 2015 and is expected to reach $28.37 billion by 2022 growing at a CAGR of 9.2% from 2015 to 2022. Increasing ageing population and raise in spinal problems due to sports injuries are the key factors driving the market growth. On other hand stringent government regulations, increasing demand for minimal invasive surgeries are hampering the market. Developing health care systems in upcoming economies on account of increasing flow of funds is the opportunity to the market.

North America accounts for the largest market share followed by Europe, due to rise in obesity cases in this region. Asia Pacific and Rest of world regions are expected to grow faster due to the high investment flow and government initiatives.

Some of the key players in the market includes B. Braun Melsungen AG, Medtronic PLC, MAQUET Holding B.V. & Co. KG., Baxter International Inc., Hemostasis, LLC, Integra Life Sciences Corporation., Johnson & Johnson, Conidian, C.R. BARD, Inc., Cryolife, Inc., Kuros Bioscience, Covidien PLC, Biom’Up, Sanofi Group, Stryker Corporation, Atrium Medical Corporation and Prolife, Inc.

Request a sample report @ https://www.wiseguyreports.com/sample-request/674291-biosurgery-global-market-outlook-2016-2022

Applications Covered:
• Thoracic Surgeries
• Reconstructive Surgeries
• Spinal Surgeries
• Cardiovascular Surgeries
• Urology Surgeries
• General Surgeries
• Gynecology Surgeries
• Neurological Surgeries
• Orthopedic Surgeries
Products Covered:
• Soft-Tissue Attachments
o Biological Mesh
 Xenografts
 Allografts
o Synthetic Mesh
• Staple Line Reinforcement Agents
• Hemostatic Agents
• Bone Graft Subsitutes
o Bone Morphogenetic Proteins (BMP)
o Bone Allografts
o Synthetic Bone Grafts
o Demineralized Bone Matrix (DBM)
• Adhesion Barriers
• Surgical Sealants
o Collagen-Based Sealants
o Fibrin Sealants
o Tissue Adhesive Glues
o Synthetic Agents/Cyanoacrylates
End Users Covered:
• Ambulatory Surgical Centers
• Home Care Settings
• Hospitals
• Cardiac Catheterization Laboratories
• Clinics
• Diagnostic Centers
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=674291

Key points in table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 End User Analysis
3.9 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biosurgery Market, By Application
5.1 Introduction
5.2 Thoracic Surgeries
5.3 Reconstructive Surgeries
5.4 Spinal Surgeries
5.5 Cardiovascular Surgeries
5.6 Urology Surgeries
5.7 General Surgeries
5.8 Gynecology Surgeries
5.9 Neurological Surgeries
5.10 Orthopedic Surgeries

6 Global Biosurgery Market, By Product
6.1 Introduction
6.2 Soft-Tissue Attachments
6.2.1 Biological Mesh
6.2.1.1 Xenografts
6.2.1.2 Allografts
6.2.2 Synthetic Mesh
6.3 Staple Line Reinforcement Agents
6.4 Hemostatic Agents
6.5 Bone Graft Subsitutes
6.5.1 Bone Morphogenetic Proteins (BMP)
6.5.2 Bone Allografts
6.5.3 Synthetic Bone Grafts
6.5.4 Demineralized Bone Matrix (DBM)
6.6 Adhesion Barriers
6.7 Surgical Sealants
6.7.1 Collagen-Based Sealants
6.7.2 Fibrin Sealants
6.7.3 Tissue Adhesive Glues
6.7.4 Synthetic Agents/Cyanoacrylates

7 Global Biosurgery Market, By End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Home Care Settings
7.4 Hospitals
7.5 Cardiac Catheterization Laboratories
7.6 Clinics
7.7 Diagnostic Centers

8 Global Biosurgery Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 B. Braun Melsungen AG
10.2 Medtronic PLC
10.3 MAQUET Holding B.V. & Co. KG.
10.4 Baxter International Inc.
10.5 Hemostasis, LLC
10.6 Integra Life Sciences Corporation.
10.7 Johnson & Johnson
10.8 Conidian
10.9 C.R. BARD, Inc.
10.10 Cryolife, Inc.
10.11 Kuros Bioscience
10.12 Covidien PLC
10.13 Biom’Up
10.14 Sanofi Group
10.15 Stryker Corporation
10.16 Atrium Medical Corporation
10.17 Prolife, Inc

Complete report details @ https://www.wiseguyreports.com/reports/674291-biosurgery-global-market-outlook-2016-2022

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here